Patients who received treatment for retroperitoneal sarcoma or spermatic cord/scrotal sarcoma at the participating institutions
Conditions
Interventions
None listed
Sponsors
Akita University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients aged 18 and 100 years with a histopathological diagnosis of sarcoma. The study included patients who initiated treatment between January 2004 and March 2025.
Exclusion criteria
Exclusion criteria: Patients who declined to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival | — |
Countries
Japan
Contacts
Public ContactShintaro Narita
Akita Univerisity School of Medicine Urology
Outcome results
None listed